- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ABT
Recent news which mentions ABT
From InvestorPlace
From Motley Fool
From Benzinga
Tickers
ABT
From Motley Fool
FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott's
March 06, 2024
From Benzinga
From InvestorPlace
Tickers
ABT
From Motley Fool
From Benzinga
Nearing Retirement? These Stocks Are as Cautious as They Come
February 28, 2024
From Motley Fool
From Motley Fool
3 Blue-Chip Stocks to Buy to Bolster Your Portfolio
February 26, 2024
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
February 26, 2024
From Benzinga
Could Abbott Laboratories Stock Help You Become a Millionaire?
February 26, 2024
Tickers
ABT
From Motley Fool
From InvestorPlace
Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment
February 23, 2024
Tickers
ABT
From Benzinga
Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth
February 23, 2024
From InvestorPlace
Peering Into Abbott Laboratories's Recent Short Interest
February 20, 2024
Tickers
ABT
From Benzinga
3 Cash Cows to Boost Your Confidence During the February Chill
February 18, 2024
From InvestorPlace
The Smartest Dividend Stocks to Buy With $400 Right Now
February 18, 2024
From Motley Fool
Cardiology's Quantum Leap: FDA's Advisory Panel Gives Thumbs Up To Abbott's Minimally Invasive Heart Valve Repair Device
February 14, 2024
From Benzinga
FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom
February 12, 2024
From Benzinga
Abbott Laboratories Is the Latest Company to Get Involved in the Weight Loss Market. Here's How.
February 11, 2024
Tickers
ABT
From Motley Fool
3 Groundbreaking Healthcare Stocks to Buy for Robust Gains
February 11, 2024
From InvestorPlace
These 2 Stocks Are Trying to Ride the Ozempic Bandwagon: Are They Buys?
February 09, 2024
From Motley Fool
7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates
February 07, 2024
From InvestorPlace
From Motley Fool
2 Stocks to Buy Near Their 52-Week Highs
February 05, 2024
From Motley Fool
2 Healthcare Dividend Kings to Buy and Hold Forever
February 04, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.